首页> 美国卫生研究院文献>The Journal of Biological Chemistry >c-Jun N-terminal Kinase (JNK)-dependent Acute Liver Injury from Acetaminophen or Tumor Necrosis Factor (TNF) Requires Mitochondrial Sab Protein Expression in Mice
【2h】

c-Jun N-terminal Kinase (JNK)-dependent Acute Liver Injury from Acetaminophen or Tumor Necrosis Factor (TNF) Requires Mitochondrial Sab Protein Expression in Mice

机译:对乙酰氨基酚或肿瘤坏死因子(TNF)的c军N末端激酶(JNK)依赖性急性肝损伤需要小鼠线粒体Sab蛋白表达。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Sustained JNK activation plays a critical role in hepatotoxicity by acetaminophen or GalN/TNF-α. To address the importance of JNK translocation to mitochondria that accompanies sustained activation in these models, we assessed the importance of the expression of a potential initial target of JNK in the outer membrane of mitochondria, namely Sab (SH3 domain-binding protein that preferentially associates with Btk), also known as Sh3bp5 (SH3 domain-binding protein 5). Silencing the expression of Sab in the liver using adenoviral shRNA inhibited sustained JNK activation and mitochondrial targeting of JNK and the upstream MKK4 (MAPK kinase 4), accompanied by striking protection against liver injury in vivo and in cultured hepatocytes in both toxicity models. We conclude that mitochondrial Sab may serve as a platform for the MAPK pathway enzymes and that the interaction of stress-activated JNK with Sab is required for sustained JNK activation and toxicity.
机译:持续的JNK活化在对乙酰氨基酚或GalN /TNF-α的肝毒性中起关键作用。为了解决在这些模型中JNK易位并伴随线粒体持续激活的重要性,我们评估了线粒体外膜中JNK潜在潜在初始靶标表达的重要性,即Sab(优先与H3结构域结合的蛋白) Btk),也称为Sh3bp5(SH3域结合蛋白5)。使用腺病毒shRNA沉默肝脏中的Sab表达可抑制JNK和上游MKK4(MAPK激酶4)的持续JNK活化和线粒体靶向,同时在两种毒性模型中均具有显着的体内和肝细胞肝损伤保护作用。我们得出结论,线粒体Sab可能充当MAPK途径酶的平台,并且应力激活的JNK与Sab的相互作用是持续JNK激活和毒性所必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号